LVTX — LAVA Therapeutics NV Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for LAVA Therapeutics NV, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	R2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	20-F	20-F	20-F	20-F
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	fx Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	7.34	15.8	133	133	95.6
Net Total Accounts Receivable
Net Total Receivables	0.219	1.48	0.734	3.25	1.7
Prepaid Expenses
Total Other Current Assets
Total Current Assets	7.62	18.2	137	141	98.9
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.15	1.5	1.95	2.08	2.49
Other Long Term Assets
Total Assets	8.79	20.5	139	143	102
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1.44	7.33	11.2	22	14.9
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	2.95	12.9	20.9	57.4	50.5
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	5.84	7.62	118	86	51.2
Total Liabilities & Shareholders' Equity	8.79	20.5	139	143	102
Total Common Shares Outstanding